NCT05196425View on ClinicalTrials.gov

Expression of PARP-1 in Multiple Sclerosis Patients

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

August 1, 2021

Primary Completion Date

March 30, 2022

Study Completion Date

April 30, 2022

Conditions
Multiple Sclerosis
Interventions
GENETIC

Blood sampling

Blood sample for detection of PARP-1 gene and correlate to changes of the optic disc, RNFL and GCC layers of the retina of MS patients

Trial Locations (1)

82511

Elshimaa A.Mateen, Sohag

All Listed Sponsors
lead

Sohag University

OTHER

NCT05196425 - Expression of PARP-1 in Multiple Sclerosis Patients | Biotech Hunter | Biotech Hunter